• Citing a ‘primary outcome’ of death, researchers cut chloroquine study short over safety concerns https://www.cnbc.com/2020/04/24/coronavirus-citing-a-primary-outcome-of-death-researchers-cut-chloroquine-study-short-over-safety-concerns.html 3 comments 24/4/2020 worldnews
• Citing a ‘primary outcome’ of death, researchers cut chloroquine coronavirus study short over safety concerns https://www.cnbc.com/2020/04/24/coronavirus-citing-a-primary-outcome-of-death-researchers-cut-chloroquine-study-short-over-safety-concerns.html 24 comments 24/4/2020 science
• A randomized phase IIb clinical trial examining high-dosage chloroquine treatment of severe COVID-19 has been halted after an interim analysis found the treatment was associated with more toxic effects and lethality, especially when taken concurrently with azithromycin and oseltamivir. https://www.cnbc.com/2020/04/24/coronavirus-citing-a-primary-outcome-of-death-researchers-cut-chloroquine-study-short-over-safety-concerns.html 8 comments 24/4/2020 science
• researchers cut chloroquine study short over safety Citing a ‘primary outcome’ of death, https://www.cnbc.com/2020/04/24/coronavirus-citing-a-primary-outcome-of-death-researchers-cut-chloroquine-study-short-over-safety-concerns.html 51 comments 24/4/2020 wallstreetbets

Linking pages

Related searches:

Search whole site: site:www.cnbc.com

Search title: Coronavirus: Citing a high risk of death, researchers cut chloroquine study short over safety concerns

See how to search.